Personalis, Inc. Tech Stack

Ultrasensitive cell-free DNA testing for cancer detection and monitoring

Biotechnology Research Fremont, California 201–500 employees Founded 2011 Public Company

Personalis develops circulating tumor DNA (ctDNA) assays for detecting minimal residual disease and cancer recurrence. The tech stack reveals a biotech operations platform: LIMS and QAD for lab workflow and manufacturing, Salesforce + Tableau for commercial execution, and specialized genomics tools (qPCR, Qubit, TapeStation). Hiring is balanced across healthcare, ops, research, and data—reflecting simultaneous pressure to scale production (reagent manufacturing, GMP compliance, quality control) while advancing assay science (MRD detection, cell-free platform development).

Tech Stack 46 technologies

Core StackSalesforce Tableau Power BI Python Java AWS VMware Active Directory GitLab ADP QAD LIMS Service Cloud Cisco Nexus Cisco Meraki Dell VxRail VAST Data Dell Isilon GCP AWS Direct Connect Red Hat Enterprise Linux Ubuntu CentOS TapeStation Qubit qPCR ADP Workforce Now macOS Jamf Google Meet+16 more

What Personalis, Inc. Is Building

◆Challenges

Quality control failures
Expanding assay capabilities
Engaging key opinion leaders
Scaling up production processes
Ensuring compliance with iso 13485/gmp
Cost-effective production
Developing novel cell-free technologies
Reducing turnaround time
Adoption of novel ctdna technologies
Improving lab process efficiency

▲Active Projects

Next personal mrd assay
Assay development
Quality management
Collaborate with commercial alliance partners
Proof of principle projects
Key opinion leader engagement
Clinical advocacy & education
Cell-free platform development
Scale-up of reagent manufacturing processes
Technology transfer of new product introduction

Hiring Activity

Accelerating30 roles · 15 in 30d

Department

Healthcare

Ops

Research

Data

Engineering

Support

Finance

Manufacturing

Seniority

Mid

Senior

Junior

Director

Staff

Notable leadership hires: Advanced Technologies Director

Company intelligence

Find more companies like Personalis, Inc. by tech stack, pain points and active projects

Get started free

About Personalis, Inc.

Personalis is a public biotech company focused on personalized cancer management through genomic profiling and minimal residual disease detection. The platform combines tumor-and-normal DNA analysis with proprietary algorithms to guide treatment selection and monitor disease evolution over time. Products serve oncologists and drug developers seeking earlier detection, more comprehensive mutation profiling, and biomarker insights for clinical trials. The company operates a vertically integrated model spanning assay development, lab operations, manufacturing, and commercial partnerships—evident in active projects around reagent scale-up, quality management, and key opinion leader engagement.

HeadquartersFremont, California

Company Size201–500 employees

Founded2011

Hiring MarketsUnited States

Frequently Asked Questions

What technology does Personalis use for testing?

Personalis uses next-generation sequencing (NGS) infrastructure including qPCR, Qubit, and TapeStation for sample analysis, paired with LIMS for lab workflow management and proprietary algorithms for tumor/normal profiling and HLA typing.

Where is Personalis headquartered?

Personalis is headquartered in Fremont, California. It is a public company founded in 2011 with 201–500 employees.

How this profile is built

Personalis, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.